Evolution of Ebola Virus Disease from Exotic Infection to Global Health Priority, Liberia, Mid-2014
M. Allison Arwady
, Luke Bawo, Jennifer C. Hunter, Moses Massaquoi, Almea Matanock, Bernice Dahn, Patrick Ayscue, Tolbert G. Nyenswah, Joseph D. Forrester, Lisa Hensley, Benjamin Monroe, Randal J. Schoepp, Tai-Ho Chen, Kurt E. Schaecher, Thomas George, Edward Rouse, Ilana J. Schafer, Satish K. Pillai, and Kevin M. De Cock
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.A. Arwady, J.C. Hunter, A. Matanock, P. Ayscue, J.D. Forrester, B. Monroe, T.-H. Chen, T. George, E. Rouse, I.J. Schafer, S.K. Pillai, K.M. De Cock); Ministry of Health and Social Welfare, Monrovia, Liberia (L. Bawo, M. Massaquoi, B. Dahn, T. Nyenswah); National Institutes of Health, Bethesda, Maryland, USA (L.E. Hensley); US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA (R.J. Schoepp, K.E. Schaecher)
Main Article
Figure 3
Figure 3. Positive PCR tests for Ebola virus infection, Liberia Institute for Biomedical Research, June 1–August 10, 2014 (n = 172).
Main Article
Page created: March 17, 2015
Page updated: March 17, 2015
Page reviewed: March 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.